GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BLIS Technologies Ltd (OTCPK:BLTHF) » Definitions » Loans Receivable

BLIS Technologies (BLIS Technologies) Loans Receivable : $0.00 Mil (As of Sep. 2023)


View and export this data going back to 2008. Start your Free Trial

What is BLIS Technologies Loans Receivable?

BLIS Technologies's Loans Receivable for the quarter that ended in Sep. 2023 was $0.00 Mil.


BLIS Technologies Loans Receivable Historical Data

The historical data trend for BLIS Technologies's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BLIS Technologies Loans Receivable Chart

BLIS Technologies Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BLIS Technologies Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BLIS Technologies Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


BLIS Technologies Loans Receivable Related Terms

Thank you for viewing the detailed overview of BLIS Technologies's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


BLIS Technologies (BLIS Technologies) Business Description

Traded in Other Exchanges
Address
442 Moray Place, Ground Floor, Dunedin, OTA, NZL, 9016
BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets two strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 both of which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from EMEA (Europe, the Middle East, and Africa).

BLIS Technologies (BLIS Technologies) Headlines

No Headlines